Cargando…
The Mechanism of Intralipid®-Mediated Cardioprotection Complex IV Inhibition by the Active Metabolite, Palmitoylcarnitine, Generates Reactive Oxygen Species and Activates Reperfusion Injury Salvage Kinases
BACKGROUND: Intralipid® administration at reperfusion elicits protection against myocardial ischemia-reperfusion injury. However, the underlying mechanisms are not fully understood. METHODS: Sprague-Dawley rat hearts were exposed to 15 min of ischemia and 30 min of reperfusion in the absence or pres...
Autores principales: | Lou, Phing-How, Lucchinetti, Eliana, Zhang, Liyan, Affolter, Andreas, Schaub, Marcus C., Gandhi, Manoj, Hersberger, Martin, Warren, Blair E., Lemieux, Hélène, Sobhi, Hany F., Clanachan, Alexander S., Zaugg, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907505/ https://www.ncbi.nlm.nih.gov/pubmed/24498043 http://dx.doi.org/10.1371/journal.pone.0087205 |
Ejemplares similares
-
Loss of Intralipid®- but Not Sevoflurane-Mediated Cardioprotection in Early Type-2 Diabetic Hearts of Fructose-Fed Rats: Importance of ROS Signaling
por: Lou, Phing-How, et al.
Publicado: (2014) -
Alterations in fatty acid metabolism and sirtuin signaling characterize early type‐2 diabetic hearts of fructose‐fed rats
por: Lou, Phing‐How, et al.
Publicado: (2017) -
Binding energies and the entry route of palmitic acid and palmitoylcarnitine into myoglobin
por: Chintapalli, Sree V., et al.
Publicado: (2018) -
l-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis
por: Yang, Juan, et al.
Publicado: (2023) -
Endothelial Barrier Disruption by Lipid Emulsions Containing a High Amount of N3 Fatty Acids (Omegaven) but Not N6 Fatty Acids (Intralipid)
por: Gueguen, Emilie, et al.
Publicado: (2022)